我为民企办实事 丨“科技专员”帮助东诚药业加快新药研发

Group 1 - The core focus is on the high-quality development of the private economy, emphasizing the need for precise policies to address the challenges faced by private enterprises [1] - The "Technology Commissioner" initiative in Yantai Huangbohai New Area aims to support high-level talent collaboration and innovation, particularly in the nuclear medicine sector [3][4] - Dongcheng Pharmaceutical has established a collaborative innovation mechanism with Yantai Harbin Engineering University to overcome talent shortages in nuclear medicine [3][4] Group 2 - The partnership has led to the development of over 10 types of medical isotopes and the publication of 4 SCI papers, with two patents currently under application [3] - Dongcheng Pharmaceutical is actively developing over 10 new nuclear drugs, including a key project "177Lu-LNC1004 targeted radioactive innovative drug" that has received clinical approval in multiple countries [3][4] - The collaboration has enhanced the supply of nuclear medicine talent and expanded the talent pool, contributing to the growth of the nuclear medicine industry [5]